The Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) on Mar. 31 released the top line results of the 12-month Phase II Imaging trial in Alzheimer’s Disease (“IMAGINE” Trial), based on draft results. Prana’s PBT2 did not meet its primary endpoint of a statistically significant reduction in the levels of beta-amyloid plaques in the brains of prodromal/mild Alzheimer’s disease patients, as measured using PiB-PET Standardized Uptake Value Ratio (SUVR). Whilst there was a reduction in the overall levels of the PiB PET signal in patients treated with PBT2, the results were confounded by an atypical reduction of levels of the PiB PET signal in the placebo group as well. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) shares after opening at $2.70 moved to $2.71 on last trade day and at the end of the day closed at $2.30. Company price to sales ratio in past twelve months was calculated as 321.62 and price to cash ratio as 5.51. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) showed a negative weekly performance of -79.34%.
Shares of The Medicines Company (NASDAQ:MDCO) have been given a consensus recommendation of “Hold” by the nine ratings firms that are presently covering the stock, AnalystRatingsNetwork reports. One analyst has rated the stock with a sell rating, four have given a hold rating and four have issued a buy rating on the company. The average 1-year price target among brokers that have covered the stock in the last year is $36.67.The Medicines Company (NASDAQ:MDCO) shares fell -15.48% in last trading session and ended the day on $24.02. MDCO return on equity ratio is recorded as 2.00% and its return on assets is 1.10%. The Medicines Company (NASDAQ:MDCO) yearly performance is -26.90%.
The You On Demand Holdings, Inc. (NASDAQ:YOD) on Mar. 31 announced its year-end operating results for the period ended December 31, 2013. YOD’s cash and cash equivalents balance at December 31, 2013 rose to $3.8 million, up from $3.3 million a year earlier, and this figure does not yet reflect the additional gross $19.0 million infusion from C Media and other investors, which was received during Q1 2014. Total operating expenses declined 22% on a Pro Forma basis and the Company’s reduced cost base along with a one-time net gain from discontinued operations, helped lead to an approximate 49% reduction in the annual net loss.You On Demand Holdings, Inc. (NASDAQ:YOD) shares moved down -13.85% in last trading session and was closed at $4.23, while trading in range of $3.85-$4.30. You On Demand Holdings, Inc. (NASDAQ:YOD) year to date performance is 87.17%.
MagneGas Corporation (NASDAQ:MNGA), which holds the credit for developing a technology “Plasma Arc Flow” which produces hydrogen based fuel from liquid waste, has announced that together with Future Energy, it aims at starting a new company in which both the parties will share equal ownership. The new company is being developed with an aim of development, licensing and commercialization of new intellectual property to limit emissions while increasing energy by the co- combustion of hydrocarbon fuels and MagneGas fuels.MagneGas Corporation (NASDAQ:MNGA) weekly performance is -3.25%. On last trading day company shares ended up $1.49. MagneGas Corporation (NASDAQ:MNGA) distance from 50-day simple moving average is 47.96%. Analysts mean target price for the company is $0.95.